This injectable medication works by mimicking the action of a naturally occurring hormone in the body called glucagon-like peptide-1 (GLP-1)
(7) BPC-157 Peptide and Tissue Damage A study was conducted to understand the extent of the angiogenic potential of the peptide beyond local wounds, ligaments, and GI tract wounds and to study its action on multiple gastrointestinal lesions on the pancreas, liver injuries, heart damage, endothelium damage, and blood pressure
Who Is a Good Candidate for BPC-157
Individuals With Persistent Gut Health Concerns: People struggling with irritable bowel syndrome, suspected leaky gut, food sensitivities, or digestive discomfort that has not responded adequately to probiotics, elimination diets, or conventional gastroenterology approaches sometimes explore BPC-157 based on its original research focus on gastric protection and gut lining integrity
This is certainly not a good sign